196 related articles for article (PubMed ID: 38245513)
1. Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia.
Gurbatri CR; Radford GA; Vrbanac L; Im J; Thomas EM; Coker C; Taylor SR; Jang Y; Sivan A; Rhee K; Saleh AA; Chien T; Zandkarimi F; Lia I; Lannagan TRM; Wang T; Wright JA; Kobayashi H; Ng JQ; Lawrence M; Sammour T; Thomas M; Lewis M; Papanicolas L; Perry J; Fitzsimmons T; Kaazan P; Lim A; Stavropoulos AM; Gouskos DA; Marker J; Ostroff C; Rogers G; Arpaia N; Worthley DL; Woods SL; Danino T
Nat Commun; 2024 Jan; 15(1):646. PubMed ID: 38245513
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer detection and treatment with engineered probiotics.
Gurbatri CR; Radford G; Vrbanac L; Coker C; Im JW; Taylor SR; Jang Y; Sivan A; Rhee K; Saleh AA; Chien T; Zandkarimi F; Lia I; Lannagan TR; Wang T; Wright JA; Thomas E; Kobayashi H; Ng JQ; Lawrence M; Sammour T; Thomas M; Lewis M; Papanicolas L; Perry J; Fitzsimmons T; Kaazan P; Lim A; Marker J; Ostroff C; Rogers G; Arpaia N; Worthley DL; Woods SL; Danino T
bioRxiv; 2023 Apr; ():. PubMed ID: 37066243
[TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial.
Petersen AM; Mirsepasi H; Halkjær SI; Mortensen EM; Nordgaard-Lassen I; Krogfelt KA
J Crohns Colitis; 2014 Nov; 8(11):1498-505. PubMed ID: 24972748
[TBL] [Abstract][Full Text] [Related]
4. Tumor-targeting engineered probiotic Escherichia coli Nissle 1917 inhibits colorectal tumorigenesis and modulates gut microbiota homeostasis in mice.
Tang H; Zhou T; Jin W; Zong S; Mamtimin T; Salama ES; Jeon BH; Liu P; Han H; Li X
Life Sci; 2023 Jul; 324():121709. PubMed ID: 37100380
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of cadmium- and mercury-induced liver and kidney damage in rats by genetically engineered probiotic Escherichia coli Nissle 1917 producing pyrroloquinoline quinone with oral supplementation of citric acid.
Raghuvanshi R; Chaudhari A; Kumar GN
Nutrition; 2016; 32(11-12):1285-94. PubMed ID: 27209211
[TBL] [Abstract][Full Text] [Related]
6. Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.
Schultz M; Watzl S; Oelschlaeger TA; Rath HC; Göttl C; Lehn N; Schölmerich J; Linde HJ
J Microbiol Methods; 2005 Jun; 61(3):389-98. PubMed ID: 15767015
[TBL] [Abstract][Full Text] [Related]
7. The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers.
Henker J; Laass M; Blokhin BM; Bolbot YK; Maydannik VG; Elze M; Wolff C; Schulze J
Eur J Pediatr; 2007 Apr; 166(4):311-8. PubMed ID: 17287932
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects resulting from oral administration of
Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
[TBL] [Abstract][Full Text] [Related]
9. Engineering Probiotic E. coli Nissle 1917 for Release of Therapeutic Nanobodies.
Gurbatri C; Danino T
Methods Mol Biol; 2024; 2748():289-305. PubMed ID: 38070121
[TBL] [Abstract][Full Text] [Related]
10. Survival of the probiotic Escherichia coli Nissle 1917 (EcN) in the gastrointestinal tract given in combination with oral mesalamine to healthy volunteers.
Joeres-Nguyen-Xuan TH; Boehm SK; Joeres L; Schulze J; Kruis W
Inflamm Bowel Dis; 2010 Feb; 16(2):256-62. PubMed ID: 19637333
[TBL] [Abstract][Full Text] [Related]
11. Prospective and challenges of live bacterial therapeutics from a superhero
Effendi SSW; Ng IS
Crit Rev Microbiol; 2023 Sep; 49(5):611-627. PubMed ID: 35947523
[No Abstract] [Full Text] [Related]
12. Expanding the toolbox of probiotic Escherichia coli Nissle 1917 for synthetic biology.
Ba F; Zhang Y; Ji X; Liu WQ; Ling S; Li J
Biotechnol J; 2024 Jan; 19(1):e2300327. PubMed ID: 37800393
[TBL] [Abstract][Full Text] [Related]
13. The beneficial effects of genetically engineered Escherichia coli Nissle 1917 in obese C57BL/6J mice.
Ma J; Wang J; Xu L; Liu Y; Gu J
Int J Obes (Lond); 2022 May; 46(5):1002-1008. PubMed ID: 35079130
[TBL] [Abstract][Full Text] [Related]
14. Construction of a new T7 promoter compatible Escherichia coli Nissle 1917 strain for recombinant production of heme-dependent proteins.
Fiege K; Frankenberg-Dinkel N
Microb Cell Fact; 2020 Oct; 19(1):190. PubMed ID: 33023596
[TBL] [Abstract][Full Text] [Related]
15. Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers.
Henker J; Laass MW; Blokhin BM; Maydannik VG; Bolbot YK; Elze M; Wolff C; Schreiner A; Schulze J
Pediatr Infect Dis J; 2008 Jun; 27(6):494-9. PubMed ID: 18469732
[TBL] [Abstract][Full Text] [Related]
16. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.
Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH
Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158
[TBL] [Abstract][Full Text] [Related]
17. Tumor Colonization and Therapy by
Gentschev I; Petrov I; Ye M; Kafuri Cifuentes L; Toews R; Cecil A; Oelschaeger TA; Szalay AA
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551519
[TBL] [Abstract][Full Text] [Related]
18. Expressing cytotoxic compounds in Escherichia coli Nissle 1917 for tumor-targeting therapy.
Li R; Helbig L; Fu J; Bian X; Herrmann J; Baumann M; Stewart AF; Müller R; Li A; Zips D; Zhang Y
Res Microbiol; 2019 Mar; 170(2):74-79. PubMed ID: 30447257
[TBL] [Abstract][Full Text] [Related]
19. Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.
Remer KA; Bartrow M; Roeger B; Moll H; Sonnenborn U; Oelschlaeger TA
Int J Med Microbiol; 2009 Nov; 299(7):467-78. PubMed ID: 19467927
[TBL] [Abstract][Full Text] [Related]
20. Influence of E. coli strain Nissle 1917 (EcN) on intestinal gas dynamics and abdominal sensation.
Hernando-Harder AC; von Bünau R; Nadarajah M; Singer MV; Harder H
Dig Dis Sci; 2008 Feb; 53(2):443-50. PubMed ID: 17712634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
